Photo: mcw.edu
Feb 1, 2026, 11:32
Qizhen Shi։ A Padua Moment for Factor VIII Gene Therapy
Qizhen Shi, Professor at Medical College of Wisconsin, Program Co-Leader of Thrombosis and Hemostasis at Versiti Blood Research Institute, shared on LinkedIn:
”Honored to share that my Blood Commentary, ‘A Padua moment for factor VIII gene therapy,’ has now been published.
The Commentary discusses a newly engineered FVIII variant with improved secretion and cofactor activity, offering a Padua-like advance for hemophilia A gene therapy by enabling efficacy at substantially lower vector doses.
Congratulations to the authors of the original study, and thank you to the Blood editorial team for the invitation.”
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome